Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Directorate Change

9 Dec 2020 07:00

RNS Number : 9794H
First Derivatives PLC
09 December 2020
 

9 December 2020

 

First Derivatives plc

("FD" or the "Group")

 

Directorate Change

 

FD (AIM: FDP.L, Euronext Growth: FDP.I) announces that Graham Ferguson has informed the Group of his intention to step down as Chief Financial Officer and from the Board on 1 January 2021. Ryan Preston, the Group's Deputy Chief Financial Officer, will be appointed Chief Financial Officer and join the Board on that date. Graham will continue as a full-time employee until 30 June 2021 to ensure a successful transition and to assist with a number of initiatives related to the Group's growth strategy.

 

Graham joined the Board in his current role in 2008 and has played a central role in the development of the business since. He is leaving to devote more time to his other interests including providing consulting services to Northern Ireland-based SMEs to assist their development.

 

Ryan was formerly Chief Financial Officer of Independent News & Media plc and at OVO Energy Retail, having spent the early part of his career in senior finance roles at Tesco, including Group Finance Director, Europe. He was appointed Deputy Chief Financial Officer at FD in January 2020.

 

Graham Ferguson commented: "I've seen FD grow from a business in Newry with great ambition, to business-leading innovation in streaming analytics at a global scale. This development is a testimony to the quality of the people I have had the pleasure to work with over with the years and it has been wonderful to be part of this journey. In Ryan, I believe that the Group has a CFO who will be a valuable addition to the FD team and assist in delivering the next phase of growth."

 

Seamus Keating, CEO of FD, commented: "Graham has been a pivotal part of FD's leadership team for more than a decade and has contributed enormously to the Group's growth. He leaves with our thanks and with FD in a strong position. We are pleased to appoint Ryan Preston as CFO with effect from 1 January 2021, confident that he can build on the strong start he has made since joining the Group earlier this year."

 

Enquiries

For further information please contact:

 

First Derivatives plc

Seamus Keating, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 5970

 

 

Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Don Harrington

Finbarr Griffin

 

+353 1 667 0420

 

 

 

FTI Consulting

Matt Dixon

Dwight Burden

Darius Alexander

 

+44 (0)20 3727 1000

 

 

Michael Ryan Preston (47) has held the following directorships or partnerships in the past five years:

 

Abbey Communications (Netherlands) B.V. TBC

Adfront Limited

Argus Newspapers Limited

Champion Printing Limited

Champion Publications Unlimited Company

Digital Odyssey Limited

Drogheda Independent Company Limited

Grabone (Ireland) Limited

Independent Abbey (Ireland) Unlimited Company

Independent Communications (International) Limited

Independent Communications (Ireland) Limited

Independent News & Media (Finance) Limited

Independent News & Media (UK) Limited

Independent News & Media Belgium

Independent News & Media Holdings (Ireland) Limited

Independent News & Media Investments Limited

Independent News and Media Limited

Independent Newspapers (Ireland) Limited

Independent Newspapers Finance PLC

Independent Newspapers Management Services Unlimited Company

Independent Newspapers Marketing Limited

Independent Star Limited

INM Regionals Limited

INM Securities (Ireland) Limited

Internet Interaction Limited

Newspread Limited

Sunday Newspapers Limited

The Kerryman, Limited

 

The Board confirms that no further disclosures are required pursuant to Schedule 2, paragraph (g) of the AIM Rules for Companies and Schedule 2, paragraph (g) of Chapter 5: Additional Rules for the Euronext Growth Market operated by Euronext Dublin in respect of the appointment of Ryan Preston to the Board of FD.

 

About FD

FD is a global technology provider with more than 20 years of experience working with some of the world's largest finance, technology, automotive, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 15 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.

 

For further information, please visit www.firstderivatives.com and www.kx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAQVLFBBLLEFBB
Date   Source Headline
1st Sep 20091:24 pmRNSExercise of Options
3rd Aug 20094:40 pmRNSDirector/PDMR Shareholding
22nd Jul 20092:42 pmRNSDirector/PDMR Shareholding
23rd Jun 20095:00 pmRNSPassing of AGM Resolutions
23rd Jun 20097:00 amRNSAGM Statement
20th May 200912:50 pmRNSDividend Declaration
20th May 20097:00 amRNSDirectorate Change
20th May 20097:00 amRNSFinal Results
24th Apr 20094:45 pmRNSDirector Declaration
1st Apr 20097:00 amRNSAcquisition
31st Mar 20093:12 pmRNSTotal Voting Rights
31st Mar 20097:00 amRNSIEX Notice
25th Mar 20092:47 pmRNSIssue of Equity
30th Jan 20094:20 pmRNSTotal Voting Rights
29th Jan 200910:07 amRNSNew Investment - Replacement
29th Jan 20099:00 amRNSFinancial Support from Invest NI
26th Jan 20097:00 amRNSOEM License Agreement
23rd Jan 20093:45 pmRNSDirector/PDMR Shareholding
16th Jan 20097:00 amRNSDirectorate Change
9th Jan 20094:11 pmRNSExercise of Options
23rd Oct 20087:30 amRNSNon Regulatory Announcement
9th Oct 20087:00 amRNSInterim Results
30th Sep 20082:23 pmRNSTotal Voting Rights
30th Sep 20087:00 amRNSIssue of Equity
15th Sep 20087:00 amRNSAcquisition
28th Aug 20083:02 pmRNSAnnual Report and Accounts
27th Aug 20087:00 amRNSDirectorate Change
13th Aug 20087:00 amRNSIEX Notice
7th Aug 20084:47 pmRNSIssue of Equity
9th Jul 20087:00 amRNSRe Contract
17th Jun 200812:40 pmRNSAGM Statement
14th May 20087:00 amRNSDirectorate Change
14th May 20087:00 amRNSFinal Results
7th May 20084:22 pmRNSNotice of Results
30th Apr 20081:39 pmRNSTotal Voting Rights
29th Feb 20082:41 pmRNSIssue of Equity
28th Feb 20087:00 amRNSTrading Statement
1st Feb 20084:17 pmRNSResult of EGM
30th Nov 200711:33 amRNSTotal Voting Rights
21st Nov 20075:01 pmRNSDirector/PDMR Shareholding
14th Nov 20071:17 pmRNSIssue of Equity
9th Nov 20074:45 pmRNSDirector/PDMR Shareholding
9th Nov 20074:42 pmRNSDirector/PDMR Shareholding
1st Nov 200710:33 amRNSTotal Voting Rights
4th Oct 20075:27 pmRNSInterim Results - Replacement
4th Oct 20077:01 amRNSInterim Results
28th Sep 20073:01 pmRNSChange of Adviser
23rd Aug 20077:00 amRNSTrading Statement
23rd Aug 20077:00 amRNSTrading Statement
17th Aug 20075:01 pmRNSWebsite Information

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.